Monday 28th July 2014 – 2.30pm – Claire Brown (in conjunction with ZOLL Medical UK Ltd)
The prestigious award for the supply of pre-hospital defibrillators to West Midlands Ambulance Service has been awarded to ZOLL® Medical UK Ltd. The decision was made after a thorough evaluation of the ZOLL X Series® monitor/defibrillator by the clinical team at West Midlands Ambulance Service. The award will see the ambulance service replace all of its existing monitors with the latest technology from ZOLL.
Weighing less than 6 kilograms, the X Series is half the size and half the weight of most full-featured defibrillators, yet powerful and built to the most rigorous standards for ruggedness. The X Series has every advanced monitoring and communication capability required by a leading ambulance service.
Andrew Carson, Medical Director for the Trust, said “The X Series monitor allows clinicians to provide improved clinical care and treatment at the patient side. These defibrillators offer the very best in clinical diagnostic tools and provide our patients optimal care in the community, before making the decision to convey them to hospital. The high specification devices will enhance the clinical treatment through EtCO2 monitoring, high-quality 12-lead ECG acquisition, and robust telemetry.”
Richard Knell-Moore, ZOLL UK Country Manager, says “We are delighted to be to continuing our partnership with the West Midlands Ambulance Service NHS Foundation Trust. The trust is one of the highest profile services in the UK and we are proud to say that they will continue to use the very latest ZOLL technologies. The Trust serves a population of 5.36 million people covering an area of more than 5,000 square miles and provides some unique challenges. The fact that the Trust chose the X Series to meet their clinical requirements and the operational demands that they face every day, is a testament to the design and functionality of the device.”
For more information on X Series please visit www.zoll.com or call 01928 595 160.
ENDS